Viewing Study NCT00103168


Ignite Creation Date: 2025-12-24 @ 5:31 PM
Ignite Modification Date: 2026-01-24 @ 11:15 PM
Study NCT ID: NCT00103168
Status: COMPLETED
Last Update Posted: 2018-07-09
First Post: 2005-02-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-12
Start Date Type: ACTUAL
Primary Completion Date: 2008-10
Primary Completion Date Type: ACTUAL
Completion Date: 2017-09
Completion Date Type: ACTUAL
First Submit Date: 2005-02-07
First Submit QC Date: None
Study First Post Date: 2005-02-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-07-06
Last Update Post Date: 2018-07-09
Last Update Post Date Type: ACTUAL